Change Language
Lorbrena Tablet 100 mg

Lorbrena Tablet 100 mg

374000 INR/Bottle

Product Details:

  • Enzyme Types Other
  • Feature Other
  • Ingredients Other
  • Application Other
  • Physical Color/Texture Tan liquid
  • Fermentation Smell Slight Smell
  • Storage Instructions Cold & Dry
  • Click to View more

Lorbrena Tablet 100 mg Price And Quantity

  • 374000 INR/Bottle
  • 1 Bottle

Lorbrena Tablet 100 mg Product Specifications

  • Other
  • Other
  • Cold & Dry
  • Other
  • Other
  • Tan liquid
  • Slight Smell

Lorbrena Tablet 100 mg Trade Information

  • Western Europe Central America Asia Australia South America Middle East Eastern Europe North America
  • All India

Product Description

Lorlatinib 100mg tablets are a medication used to treat non-small cell lung cancer (NSCLC) that has spread to other parts of the body and has certain genetic mutations. It belongs to a class of drugs called ALK and ROS1 inhibitors, which work by blocking certain proteins that promote cancer growth.

The medication is taken orally, usually once a day, with or without food. It is important to take the medication exactly as prescribed and to never take more or less than the prescribed dose.

Lorlatinib 100mg tablets may cause some side effects, including fatigue, nausea, diarrhea, and constipation. It may also cause more serious side effects, such as lung problems or high blood pressure. If you experience any severe or persistent side effects, be sure to contact your doctor or healthcare provider.

As with any cancer medication, Lorlatinib 100mg tablets may not be suitable for everyone. It is important to discuss any medical conditions, allergies, or other medications you may be taking with your healthcare provider before starting treatment. It is also important to inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding, as the medication may harm an unborn or nursing baby.

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Anti Cancer Medicine' category

Back to top